MANIPALHOS logo

Manipal Health Enterpri L

MANIPALHOS·NSE·
760.60 +14.50 (+1.94%)
Market Cap95003.12 Cr
PE Ratio208.96
Volume12,01,545
Day High - Low767.00 - 746.00
52W High-Low815.00 - 625.45

Manipal Health Enterpri L (MANIPALHOS): company summary

The company's revenue grew 15.5% annually, but net profit fell 19.6% year-on-year.

Manipal Health Enterpri L (MANIPALHOS) is a mid-cap Healthcare company valued at ₹95,003 crore operating in Healthcare Services on the NSE and BSE.

Recent price move
Manipal Health Enterpri L last traded at ₹760.6, modestly up 1.94% on the day.
Recent developments
On 2026-08-07, the company's IPO was subscribed 5x on closing day, with a fresh issue of equity shares worth up to ₹8,000 crore and an offer for sale of up to 2.16 crore equity shares by existing shareholders. On 2026-08-05, the stock traded at ₹651, a 11% premium over the IPO price of ₹590, and the IPO listed with a grey market premium of around ₹3, indicating an estimated listing price of ₹593.
Financial performance
The company's revenue grew 15.5% annually, but net profit fell 19.6% year-on-year. In the latest quarter, revenue rose 28.1% compared to the same quarter a year earlier, but net profit dropped 7.9%. The net profit margin narrowed 5.2 percentage points to 12.0%, while return on equity remained at 8.6%.
Valuation multiples
The stock trades at 209.0 times earnings, a premium to the Healthcare median of 32.2, 5.87 times book value.
Things to watch
The stock is 12.0% below its 52-week high. Net profit margin fell 5.2 percentage points to 12.0%, and net profit declined 19.6% annually. The latest quarter saw a 7.9% drop in net profit despite a 28.1% rise in revenue.
Where it stands
The company's revenue grew 15.5% annually, but net profit fell 19.6% year-on-year. The latest quarter saw revenue rise 28.1% compared to the same quarter a year earlier, but net profit dropped 7.9%. The stock is 12.0% below its 52-week high, and the net profit margin narrowed 5.2 percentage points to 12.0%.

Summarised by DocStoX's model on 2026-09-12 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
6.2/10
Fair
Fair Value
Sign in to see
ROE
8.56%
Average
P/E
208.96x
Expensive
Debt / Equity
0.48
Moderate
Industry
Healthcare
Healthcare Services
Overall View
Mixed

Price performance

Day746.00
767.00
52W625.45
815.00
DocStoX take

Supported by risk (9.0) and growth (8.3), but held back by valuation (0.0). Risk looks strong at 9.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.2
/10
Fair
Quality
Solid
ROE 8.6%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +20.6% 5Y CAGR
Risk
Low risk
D/E 0.48
Momentum
Strong
71% of 52-week range

At a glance

Market Cap
₹95,003 Cr
52W High / Low
₹815 / ₹625
Dividend Yield
0.00%
Promoter Holding
72.08%
EPS (TTM)
₹3.64
Book Value
₹124.89

Key highlights

  • Profit compounding 30% a year
  • Profitable in all of the last 5 years
  • Revenue compounding 21% a year
  • Valuation is weak (0.0/10)
  • Expensive at 200× earnings
3 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Services

MANIPAL HEALTH ENTERPRI L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.